Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Giessen – page 4

245 clinical trials in Giessen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Giessen at a glance
245
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

245 trials in Giessen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Insel Gruppe AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ltp001
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivosidenib
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:GlaxoSmithKline Biologicals
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Flecainide Acetate
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LTI-03
  • Sponsor:Rein Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Universitaetsspital Basel
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Revolution Medicines Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Johnson & Johnson Enterprise Innovation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Giessen

What the registry says about research in the country

01 Respiratory Disease Research

Innovative trials focusing on pulmonary hypertension and lung cancer treatments, including evaluation of novel therapies for various stages of NSCLC and rare pulmonary conditions.

  • Pulmonary Arterial Hypertension
  • Non-Small Cell Lung Cancer
  • Idiopathic Pulmonary Fibrosis

Multiple studies are investigating targeted therapies and combination treatments for advanced lung diseases.

02 Rare Disease Studies

Comprehensive research into rare genetic conditions, including Leber congenital amaurosis and Niemann-Pick disease, with trials testing innovative therapeutic approaches.

  • Ataxia Telangiectasia
  • Spinal Muscular Atrophy
  • Hunter Syndrome

These studies aim to improve treatment options for patients with rare genetic disorders.

03 Oncology Research

Advanced clinical trials examining new treatments for various cancers, particularly focusing on head and neck cancer and innovative immunotherapy combinations.

  • Metastatic Lung Cancer
  • Ovarian Cancer
  • Squamous Cell Carcinoma

Studies are evaluating novel drug combinations and targeted therapies for better treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.